Gennex Laboratories moves up on planning to raise funds through permissible modes

29 Mar 2022 Evaluate

Gennex Laboratories is currently trading at Rs. 7.75, up by 0.19 points or 2.51% from its previous closing of Rs. 7.56 on the BSE.

The scrip opened at Rs. 7.78 and has touched a high and low of Rs. 7.83 and Rs. 7.31 respectively. So far 339397 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 1 has touched a 52 week high of Rs. 12.90 on 07-Jul-2021 and a 52 week low of Rs. 3.72 on 30-Mar-2021.

Last one week high and low of the scrip stood at Rs. 8.13 and Rs. 7.31 respectively. The current market cap of the company is Rs. 97.79 crore.

The promoters holding in the company stood at 22.05% and Non-Institutions held 77.95%.

Gennex Laboratories is planning to raise funds by issuance of equity shares or any other securities, through permissible modes including but not limited to a rights issue, as may be permitted under applicable law and subject to such regulatory/ statutory approvals, as may be required. A meeting of Board of Directors of the Company will be held on April 06, 2022 to consider the same.

Gennex Laboratories is engaged in the manufacture and export of bulk drugs and intermediates. The product range of the company includes Guaiphenesin,Methocarbamol,Fluconazole and Phenazopyridine.


Gennex Lab Share Price

16.90 1.38 (8.89%)
15-May-2024 10:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1522.10
Dr. Reddys Lab 5934.00
Cipla 1411.00
Zydus Lifesciences 994.30
Lupin 1638.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.